Trial
NCT06626971
The Use of ARA290 for the Treatment of Diabetic Macular Oedema
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Belfast Health and Social Care Trust
Collaborators
Araim Pharmaceuticals, Inc.
Condition
Diabetic Macular Oedema
Intervention
ARA290
Why stopped
Expiry of study drug - no replacement available.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-04